General Information
Version
2.1
Revision date
2024-10-01
Product name
POWERLEES (Ex POWERLEES Rouge)
1.2.1 Relevant identified uses
Professional use Industrial/Professional use spec
Manufacturer Name
LAFFORT FRANCE SAS
Emergency telephone
+359 2 9154 233, 1-800-268-9017, 1-800-567-8911, (604) 682-5050, +86 10 831 32 046, +385 1 234 8342, +420 224 919 293, +420 224 915 402, +45 82 12 12 12, +995 99 533320, +30 2 10 779 3777, +36 80 20 11 99, +972 4 854 1900, +81-29-856-3566, +81-72-727-2499, +7 3272 925 868, +356 2545 6504, +56 2 2 247 3600, +48 42 63 14 724, +40 21 230 8000, +7 495 628 1687, +381 11 360 84 40, +386 522 52 83, 0344 892 0111, +44 20 7188 7188, 1-800-222-1222
Icons in SDS
Company Information
company name
LAFFORT FRANCE SAS
e-mail address of the competent person responsible for the Safety Data Sheet
info@laffort.com, laffortitalia@laffort.com, laffortusa@laffort.com
GHS Information
Signal word
-
Hazard Codes
Hazard statements (CLP)
H334
Hazard statements
Code
Statements
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice
Hazard pictograms
GHS08
Signal word
-
Hazard statements
H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary statements
P261 - Avoid breathing spray, mist, fume, gas, dust, vapours. P285 - In case of inadequate ventilation wear respiratory protection. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342+P311 - If experiencing respiratory symptoms: Call a POISON CENTER, doctor.
Supplemental label elements
EUH208 - Contains Glucanase enzyme(62213-14-3). May produce an allergic reaction. EUH210 - Safety data sheet available on request.
Other hazards which do not result in classification
May cause sensitization by inhalation and skin contact. mild eye irritation. mild skin irritation. Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Hazard pictograms (CLP)
